H. Lundbeck A/S is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders, engaging in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.